|
Real-time Estimate
Cboe BZX
22:06:19 13/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 594.96 USD | +0.28% |
|
+6.22% | +22.52% |
| 11-13 | United Therapeutics Insider Sold Shares Worth $5,570,085, According to a Recent SEC Filing | MT |
| 11-13 | United Therapeutics Insider Sold Shares Worth $5,642,870, According to a Recent SEC Filing | MT |
| Market Cap | 25.27B 22.9B 21.18B 19.11B 36.01B 2,383B 37.28B 254B 101B 1,273B 94.82B 92.81B 4,040B | P/E 2026 * |
23.8x | P/E 2027 * | 18.9x |
|---|---|---|---|---|---|
| Enterprise Value | 22.48B 20.37B 18.84B 17B 32.03B 2,119B 33.16B 226B 89.74B 1,132B 84.35B 82.56B 3,594B | EV / Sales 2026 * |
6.9x | EV / Sales 2027 * | 5.93x |
| Free-Float |
52.87% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| UTHR | Delayed | |
CBOE
| UTHR | Real-time | |
|
Tradegate
| UTH | Real-time | |
|
Deutsche Boerse AG
| UTH | Delayed | |
|
Börse Stuttgart
| UTH | Delayed | |
|
Boerse Muenchen
| UTH | Real-time | |
|
Berne S.E.
| UTH | End-of-day quote | |
|
Xetra
| UTH | Delayed |
Last Transcript: United Therapeutics Corporation
| 1 day | +0.28% | ||
| 1 week | +6.22% | ||
| Current month | -0.29% | ||
| 1 month | +9.86% | ||
| 3 months | +19.09% | ||
| 6 months | +3.01% | ||
| Current year | +22.52% |
| 1 week | 556.63 |  | 598.8 |
| 1 month | 523.95 | | 614.23 |
| Current year | 455.63 | | 614.23 |
| 1 year | 455.63 | | 614.23 |
| 3 years | 208.62 | | 614.23 |
| 5 years | 158.38 | | 614.23 |
| 10 years | 74.31 | | 614.23 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 26/06/1996 | |
| President | 54 | 26/06/2016 | |
James Edgemond
DFI | Director of Finance/CFO | 58 | 13/03/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 78 | 01/01/2002 |
| Chairman | 71 | 26/06/1996 | |
Louis Sullivan
BRD | Director/Board Member | 92 | 01/01/2002 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/5/26 A | Sell | Chief Executive Officer | -1,960 | 0.0046% | ||
| 11/5/26 A | Exercice | Chief Executive Officer | 26,540 | 0.0619% | ||
| 11/5/26 A | Exercice | General Counsel | 24,900 | 0.0581% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.28% | +6.22% | +29.13% | +164.92% | 25.27B | |
| +1.42% | +6.95% | +41.57% | +136.34% | 1,271B | |
| +0.95% | +3.70% | +46.70% | +94.02% | 683B | |
| +0.27% | +1.39% | +27.15% | +113.04% | 520B | |
| -0.44% | +3.69% | +39.60% | +69.51% | 389B | |
| +0.13% | +0.18% | +58.18% | +43.46% | 362B | |
| -0.12% | +0.74% | +26.78% | +58.43% | 304B | |
| +0.37% | +0.37% | +3.62% | +36.44% | 286B | |
| -0.29% | +1.20% | +38.68% | +74.72% | 253B | |
| +0.21% | +0.81% | +34.38% | +124.53% | 208B | |
| Average | +0.32% | +2.05% | +34.58% | +91.54% | 430B | |
| Weighted average by Cap. | +0.63% | +2.69% | +37.70% | +96.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.26B 2.95B 2.73B 2.46B 4.64B 307B 4.81B 32.81B 13.01B 164B 12.23B 11.97B 521B | 3.6B 3.27B 3.02B 2.73B 5.14B 340B 5.32B 36.29B 14.39B 182B 13.52B 13.24B 576B |
| Net income | 1.14B 1.04B 958M 865M 1.63B 108B 1.69B 11.51B 4.56B 57.58B 4.29B 4.2B 183B | 1.41B 1.28B 1.18B 1.07B 2.01B 133B 2.08B 14.22B 5.64B 71.14B 5.3B 5.19B 226B |
| Net Debt | -2.79B -2.53B -2.34B -2.11B -3.98B -263B -4.12B -28.11B -11.14B -141B -10.48B -10.25B -446B | -3.89B -3.53B -3.26B -2.94B -5.55B -367B -5.74B -39.2B -15.54B -196B -14.61B -14.3B -622B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | $596.56 | +0.55% | 111,638 |
| 12/11/26 | $593.31 | -0.39% | 338,726 |
| 11/11/26 | $595.66 | +1.20% | 369,686 |
| 10/11/26 | $588.61 | +1.06% | 461,368 |
| 09/11/26 | $582.46 | +3.64% | 571,821 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- UTHR Stock
Select your edition
All financial news and data tailored to specific country editions
